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Hashimoto's thyroiditis (HT) is an autoimmune disease of the thyroid 
associated with goiter and hypothyroidism. Although there exists a clear 
association between HT and lymphomas of the thyroid, the association 
between HT and thyroid cancer remains unclear. To evaluate this further, 
we retrospectively reviewed the pathology reports for all thyroidectomy 
specimens as well as the records of patients admitted to the University of 
Michigan Medical Center, Ann Arbor, Michigan, U.S.A., over a 10-year- 
period (1975-1985) with the diagnosis of HT or chronic lymphocytic 
thyroiditis (CLT). Eight hundred and nine pathologic diagnoses were 
recorded for 816 thyroidectomy specimens from 793 patients. Further- 
more, 180 of 228 patient chart records were available for review. Only 128 
patients satisfied our criteria for the diagnosis of HT. HT or CLT were 
diagnosed in 147 (18.2%) of 809 thyroid specimens. HT occurred concur- 
rently with thyroid cancer in 24% of all cases of HT, whereas, HT 
occurred concurrently with benign thyroid disease in 71% of all cases of 
HT in all thyroid specimens. Furthermore, HT was associated with 43 
(22%) of 195 cases of thyroid cancer. There were 111 (87%) women and 
17 (13%) men of 128 patients whose charts were reviewed. The mean age 
was 49 -+ 14 years. Ninety-eight (77%) of the patients presented with 
goiters and 57 (45%) presented with dominant thyroid masses, 38 (67%) 
of which were solitary nodules. One patient (0.8%) presented with a 
recurrent laryngeal nerve palsy (RLNP) and 12 (9%) presented with 
tracheal compression. Only 29 (38.2%) of 76 patients measured had 
positive antithyroglobulin (ATG) titers, whereas 65 (87%) of 75 patients 
measured had positive antimicrosomal (AM) titers. Seventy (55%) pa- 
tients were evaluated with either a technetium or 131I thyroid scan. There 
was a heterogeneous pattern to the scan in 75% of these patients. 
Niney-one (71%) patients were initially treated with thyroid suppression. 
However, 27 (21%) required thyroidectomy for initial management. 
Ultimately, 60% required thyroidectomy and 37% required none. The 
major indication for surgical intervention was the presence of a dominant 
mass in 40 (52%) of 77 patients. Only 17 (13%) patients were found to 
have thyroid cancer concomitant with HT and 3 (2 %) had lymphoma with 
HT. The incidence of minimal (occult) cancer in a study of 100 consecutive 
autopsies at this institution was 13%. We believe that these data suggest 
that the association of HT with thyroid cancer is relative, at best. It will 
be necessary to prospectively follow both a large group of patients with 
HT and a control group of patients without HT for the incidence of 
thyroid cancer in each before this issue can be appropriately addressed. 
Hashimoto 's  thyroiditis (HT) is an autoimmune disease of the 
thyroid that is associated with goiter and hypothyroidism and 
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has a distinct prevalence in women [1]. There appears to be a 
clear association between HT and lymphoproliferative disor- 
ders including lymphomas of the thyroid [2, 3]. However ,  the 
relationship between HT and thyroid carcinoma remains un- 
clear. This remains true despite recent evidence to support the 
view that HT is a predisposing factor in the development of 
thyroid carcinoma [4]. Dailey et al. were the first to report a 
significant relationship between HT and thyroid carcinoma [5]. 
Subsequently, there has been considerable controversy over 
the accuracy of that finding with reports of incidences of thyroid 
carcinoma coexisting with HT ranging from 1% to 23% [6-14]. 
It is hypothesized that HT can be attributed to an inherited 
isolated defect in immunoregulation in which there is an organ- 
specific defect in suppressor T-cell function [15, 16]. Since such 
a defect will also adversely affect immune surveillance, it 
remains possible that, given this inherited genetic disposition, a 
patient susceptible to thyroiditis may also be more susceptible 
to the growth and development of a thyroid neoplasm. More- 
over, in HT there is an inhibition of the production of iodinated 
organic compounds in the glands of these patients. Consequent- 
ly, there is a reduction in the production of thyroxine or 
triiodothyronine and this course of events stimulates the feed- 
back of increased secretion of TSH [1]. It is argued, therefore, 
that the chronic stimulation of the thyroid by elevated levels of 
TSH may, in addition to inducing goiter formation, initiate or 
promote the growth of  thyroid neoplasms. 
The purpose of this retrospective study was to further eval- 
uate the relationship between HT and thyroid cancer in our 
clinical experience and to determine whether the incidence of 
coexistent HT in thyroid cancer was, indeed, significantly 
higher than the incidence of  coexistent HT in benign thyroid 
disease. 
Methods 
The pathology reports for all operative thyroidectomy speci- 
mens obtained at the University of Michigan Medical Center, 
Ann Arbor, Michigan, U.S.A.,  over a 10-year-period beginning 
in January, 1975 and ending in December,  1985 were retrospec- 
tively reviewed. During this 10-year interval, 809 pathologic 
diagnoses were recorded for 816 thyroidectomy specimens 
submitted for pathologic evaluation. This data resulted from the 
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Fig. 1. Papillary cancer coexistent with diffuse 
lymphoplasmacytic infiltration and prominent 
germinal centers. The large cells with 
generous eosinophilic cytoplasm, irregular 
nuclei with prominent nucleoli are Hiirthle 
cells that represent the eosinophilic 
metaplastic change associated with the 
follicular epithelium in Hashimoto's 
thyroiditis. 
Fig. 2. An example O f a germinal center in a 
case of Hashimoto's thyroiditis with 
prominent lymphocyte and plasmocyte 
infiltralion. Askanazy or Hiirthle cells are also 
present. 
management of 793 patients with thyroid disorders or clinical 
findings pertaining to the thyroid for which some form o f  
thyroidectomy(ies) was indicated. The histologic criteria used 
to make the diagnosis of  HT included diffuse lymphoplas- 
macytic infiltration (Figs. 1, 2), germinal centers (Fig. 2), 
enlarged epithelial cells with large nuclei and eosinophilic 
cytoplasm (Askanazy or H~irthle cells), fibrosis, distorted ar- 
chitecture, and small follicles depleted of thyroglobulin (Fig. 3). 
Review of the pathologic description of the microscopic find- 
ings was meticulous in order to distinguish between cases of 
nonspecific thyroiditis and/or focal thyroiditis associated with 
thyroid cancer. However ,  ultimately, the pathological diagnosis 
was accepted as that recorded on the final pathology report. 
During a concurrent time interval, 228 patients were identified 
by the Medical Records department of  the University Hospital 
as having been coded with the diagnosis of HT. The medical 
records of 180 of these were available for review. One hundred 
and twenty-eight patients satisfied our criteria for the diagnosis 
of HT. These criteria included: hypothyroidism associated with 
a thyroid goiter; positive thyroid antithyroglobulin (ATG) 
and/or antimicrosomal (AM) antibodies associated with a thy- 
roid mass or hypothyroidism, or classic pathologic findings of 
HT in the surgical specimen if a thyroidectomy was performed. 
Differences between frequency distributions observed were 
tested for using the chi-square test for independent samples 
[17]: P -< 0.05 was accepted as statistically significant. 
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Table 1. Summary of all thyroidectomy procedures during the period 
1975-1985. 
Operation No. of cases % of all procedures 
Lobectomy and/or isthmusectomy 399 48.9 
Subtotal thyroidectomy 226 27.7 
Total thyroidectomy 120 14.7 
Completion thyroidectomy 41 5.0 
Near total thyroidectomy 20 2.5 
Nodulectomy 10 1.2 
Total 816 100 
Resu l t s  
Pathology Review 
Seven hundred and ninety-three patients underwent 816 ~ thy- 
roidectomies. These 816 thyroidectomies were comprised of 
120 (14.7%) total thyroidectomies,  20 (2.5%) near total thyroid- 
ectomies, 41 (5.0%) completion thyroidectomies,  226 (27.7%) 
subtotal thyroidectomies,  399 (48.9%) lobectomies and/or 
isthmusectomies,  and 10 (1.2%) nodulectomies (Table 1). Eight 
hundred and nine pathologic diagnoses were reported based on 
the pathologic evaluation of the above thyroidectomy speci- 
mens. One hundred and ninety-five (24%) of 809 were thyroid 
carcinomas, 165 (84.6%) of which were well-differentiated 
thyroid carcinomas (Table 2). There were 10 (5.1%) lymphomas 
of the thyroid, 9 (4.6%) pure medullary thyroid carcinomas, 4 
(2.1%) anaplastic or undifferentiated thyroid carcinomas as well 
as 3 squamous cell thyroid carcinomas, and 2 cases each of 
mixed medullary/papillary and metastatic thyroid carcinomas, 
respectively. 
A diagnosis of either HT or chronic lymphocytic thyroiditis 
(CLT) was made either individually or concurrently with an- 
other diagnosis in 147 (18.2%) of 809 pathologic cases reviewed. 
Although it is possible to distinguish between HT and CLT 
based on strictly pathologic criteria (for example, the absence 
of Askanazy or HOrthle cells in the latter), for the purpose of 
Fig. 3. An example of Hashimoto's thyroiditis 
demonstrating germinal center, distOrted 
architecture, and loss of colloid or depleted 
follicles. 
Table 2. Summary of the incidences of thyroid carcinoma in all thy- 
roidectomy specimens during the period 1975-1985. 
Thyroid cancer-- No. of % of thyroid % of all 
Cell type cases cancer specimens 
Papillary 143 73.3 17.7 
Hfirthle 12 6.2 1.5 
Follicular 10 5.1 1.2 
Lymphoma 10 5.1 1.2 
Medullary 9 4.6 1.1 
Anaplastic 4 2.1 0.5 
Squamous ceil 3 1.5 0.4 
Metastatic 2 1.0 0.2 
Medullary/papillary 2 1.0 0.2 
Total 195 100 24.0 
this review both entities were combined and considered collec- 
tively as HT. Hashimoto 's  thyroiditis was diagnosed in associ- 
ation with concurrent thyroid carcinoma in 43 (29.3%) of 147 
pathologic cases with HT. 
Thirty-six cases (83.7%) of HT concurrent with thyroid 
carcinoma were due to well-differentiated thyroid carcinoma 
(Table 3). Four  cases (9.3%) were due to thyroid lymphoma. On 
the other hand, a total of 104 (70.7%) of  147 cases of HT were 
associated with benign thyroid disease. This occurred in an 
enlarged thyroid gland with either a single thyroid nodule or 
multiple nodules in virtually a l l  cases (Table 4). Overall, HT 
was associated with 43 (22.1%) of 195 cases of thyroid cancer in 
this series, whereas HT was associated with 104 (16.9%) of 614 
cases of benign thyroid disease in the series. There was no 
statistically significant difference between the frequency distri- 
bution of HT associated with thyroid carcinoma versus benign 
thyroid disease (p > 0.10). 
To examine further the association of HT with concurrent 
well-differentiated thyroid carcinoma, it was observed that 30 
(21.0%) of 143 papillary thyroid carcinomas were associated 
with concurrent HT. Furthermore,  papillary thyroid carcinoma 
represented 70% of all the cases of HT diagnosed to be 
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Table 3, Summary of all surgical specimens with concurrent thyroid 
carcinoma and Hashimoto's or chronic lymphocyte thyroiditis during 
the period 1975-1985. 
% of cases 
with % of all 
No. of concurrent cases of 
Histology a cases cancer b thyroiditis 
Papillary and thyroiditis 30 69.8 20.4 
Follicular and thyroiditis 5 11.6 3.4 
Lymphoma and thyroiditis 4 9.3 2.7 
Hiirthle cell and thyroiditis 1 2.3 0.7 
Medullary and thyroiditis 1 2.3 0.7 
Anaplastic and thyroiditis 1 2.3 0.7 
Metastatic and thyroiditis 1 2.3 0.7 
Total cases of malignant 
disease and thyroiditis 43 100 29.3 
Total cases of 
thyroiditis 147 
aAll thyroid carcinomas with Hashimoto's or chronic lymphocytic 
thyroiditis. 
bConcurrent thyroid cancer and Hashimoto's thyroiditis. 
Table 4. Summary of all surgical specimens with Hashimoto's or 
ch~ronic lymphocytic thyroiditis in benign thyroid disease. 
% of cases with 
No. of thyroiditis and % of cases of 
Histology cases benign lesion thyroiditis 
Hashimoto's thyroiditis 74 71.2 50.3 
Chronic lymphocytic 
thyfoiditis 7 6.7 4.8 
Adenoma and thyroiditis ~ 7 6.7 4.8 
Goiter and thyroiditis 6 5.8 4.1 
Diffuse and adenomatous 
hyperplasia and 
thyroiditiS 5 4.8 3.4 
Colloid nodules and 
thyroiditis 3 2.9 2.0 
Hfirthle cell tumor and 
thyroiditis 2 1.9 1.4 
Total cases of benign 
disease and 
thyroiditis 104 100 70.8 
Total cases of 
thyroiditis 147 
aThyroiditis = Hashimoto's and/or chronic lymphocytic thyroid- 
itis. 
associated with thyroid carcinoma. Five (50%) of 10 follicular 
thyroid carcinomas were associated with HT. One (8.3%) of 12 
Hfirthle cell thyroid carcinomas were similarly associated with 
HT. In comparison to these distributions for well-differentiated 
thyroid carcinoma, 4 (40%) of 10 lymphomas of the thyroid 
were associated with HT. 
The incidence of thyroid nodules in this series was 184 
(22.7%) of 809 cases. One hundred and sixty-five (89.7%) of 184 
thyroid nodules were colloid, 8 (4.3%) of 184 were follicular. 
The remainder were either atypical, cellular, or nonspecific 
thyroid nodules, Only 3 (1.6%) of 184 thyroid nodules were 
observed to contain concomittant HT. It should be noted here 
that cases with nonencapsulated nodules found in glands with 
diffuse involvement demonstrating findings that were consistent 
with HT were simply considered to represent HT. 
Table 5. Hashimoto's thyroiditis: Metabolic status. 
Clinical criteria Thyroid function tests 
Metabolic status n, (%) n, (%) 
Euthyroid 74, (58.7%) 53, (50%) 
Hypothyroid 46, (36.5%) 50, (47.2%) 
Hyperthyroid 6, (4.8%) 3, (2.8%) 
Total 126, (100%) 106, (100%) 
Patient Chart Review 
There were 111 (87%) women and 17 (13%) men of 128 patients 
who satisfied the criteria for the diagnosis of HT. This repre- 
sents a female to male ratio of 7:l for this series. The mean age 
for women was 39 +- 19 years and ranged from 4 to 80 years. 
The mean age for men was 45 - 16 years and ranged from 15 to 
69 years. The mean duration of follow-up for this group of 
patients was 4.0 -+ 4.4 years. Eight (6.3%) of 128 patients had a 
positive past medical history for having received prior head and 
neck irradiation. However, 7 (87.5%) of 8 patients with a 
history of previous head and neck irradiation had HT alone (1 
patient had laboratory values for thyroid function in the hyper- 
thyroid range, although the patient was clinically euthyroid). 
Only 1 (12.5%) of 8 patients with a history of previous head and 
neck irradiation had concurrent HT and thyroid cancer. 
Ninety-eight (76.6%) of the patients were found to have 
goiters on presenting physical examination, 85 (87.6%) of which 
were bilateral. Palpable thyroid nodule(s) were noted in 57 
(44.5%), 38 (66.7%) of which were solitary and 19 (33.3%) of 
which were multiple. One patient (0.8%) of 128 presented with 
a recurrent laryngeal nerve palsy and was subsequently proven 
to have thyroid cancer concurrent with HT. Twelve (9.4%) of 
128 patients presented with either tracheal deviation or com- 
pression, 2 (16.7%) of which were subsequently proven to have 
thyroid cancer concurrent with HT. 
The clinical diagnosis regarding metabolic status was noted in 
126 patients. Seventy-four patients (58.7%) were noted to be 
euthyroid, 46 (36.5%) were noted to be hypothyroid, and 6 
(4.8%) were noted to be hyperthyroid based on purely clinical 
criteria. This compared with thyroid function studies consistent 
with a euthyroid status in 53 (50%) of 106 patients, a hypothy- 
roid status in 50 (47.2%), and a hyperthyroid status in 3 (2.8%) 
(Table 5). 
Only 29 (37.2%) of 78 patients measured had positive serum 
antithyroglobulin antibodies, whereas 64 (82.1%) had positive 
serum antimicrosomal antibodies. 
Seventy patients (55.6%) of 126 were evaluated with either a 
99m technetium or 1311 thyroid scan. A heterogeneous scan was 
observed in 75% of those studied. Eleven (61%) of 18 patients, 
for which there was specific data, had increased uptake on 
thyroid scan. In 29 (44.6)% of 65 thyroid scans a nodule was 
identified. Twenty-three (79.3%) of 29 thyroid nodules on 
thyroid scan were cold, whereas 5 (17.2%) were hot and in one 
the functional status was not stated. The incidence of thyroid 
carcinoma was 6 (31.6%) of 19 cold nodules. Seven (36.8%) of 
19 cold nodules were colloid nodules, 2 (10.5%) cold nodules 
were benign adenomas, and 2 (10.5%) cold nodules were 
lymphomas of the thyroid. There was no instance of thyroid 
carcinoma seen in a hot nodule in this group of patients. One 
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Table 6. Summary of initial management in patients with Hashimoto;s 
thyroiditis. 
Treatment No. of cases % of total 
TSH suppression 91 73 
Subtotal thyroidectomy 24 19 
Total thyroidectomy 3 2 
No treatment 3 2 
Other 4 3 
Total 125 100 
(33.3%) of 3 hot nodules was a lymphoma of the thyroid and the 
remaining 2 hot nodules were benign thyroid lesions. 
Ninety-one (72.8%) of 125 patients were initially treated with 
thyroid replacement (TSH suppression). However,  27 (21.6%) 
patients required thyroidectomy (24 subtotal thyroidectomies 
and 3 total thyroidectomies) for the initial management of their 
HT. Ultimately, 77 (60.2%) of 128 patients with HT required 
thyroidectomy to successfully manage their thyroiditis. Forty- 
six (37%) of  124 patients required no surgical intervention and 4 
(3.2%) underwent needle biopsy which either confirmed or 
established the diagnosis of HT (Table 6). 
The major indication for thyroidectomy in this group of 
patients was the presence of a dominant mass in 40 (51.9%) of 
77 patients, 31% of which had thyroid carcinoma (Table 7). Two 
(6.9%) of 29 patients with dominant masses as an indication for 
thyroidectomy had lymphoma of the thyroid and 18 (62%) with 
dominant masses as the indication for thyroidectomy had 
benign thyroid disease. 
Ninety-six (75%) of 128 patients had HT as their sole diag- 
nosis. There were 5 (3.9%) patients with findings consistent 
with Hashitoxicosis,  however,  3 of these patients had past  
medical histories of Graves '  disease and probably represented 
Graves '  disease with concurrent HT. Five patients (3.9%) had 
goiters with hypothyroidism both clinically and biochemically 
as the sole criteria for their diagnosis. Two patients (1.6%) had 
HT associated with benign adenomas. Only 17 (13.3%) patients 
of this group of 128 were found to have thyroid carcinoma 
concomitant with their HT and 3 (2.3%) had lymphoma of the 
thyroid concomitant with their HT (Table 8). The incidence of 
minimal (occult) thyroid carcinoma in a study of 100 consecu- 
tive autopsies at this institution was 13% [18]. 
D i s c u s s i o n  
Endemic goiter is the most common thyroid disease today [19]. 
The addition of iodine to the diet has actually increased the 
incidence of Hashimoto 's  thyroiditis, which falls into the cate- 
gory of endemic goiter. This is supported by the observation 
that lymphocytes are not found in the thyroid glands of iodine- 
deficient endemic goiters. The introduction of iodine into the 
diet in an endemic area is, however,  accompanied by increasing 
lymphocytic infiltration with the subsequent development of 
HT [19]. This response is apparently preconditioned in a certain 
portion of the population by an underlying inherited or acquired 
biochemical defect in the thyroid, thus, impairing organic iodine 
binding. These facts may well explain why HT is probably the 
most common cause of diffuse goiter in the United States with 
an incidence in autopsy specimens of 2% [20, 21]. Furthermore,  
the incidence of HT has been documented to be increasing with 
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Table 7. Indications for thyroidectomy among patients with Hashimo- 
to's thyroiditis. 
Indication No. of cases % of total 
Dominant mass 40 52 
Compressive symptoms 8 10 
Increasing size 7 9 
Medical failure 5 7 
Cosmesis 3 4 
Airway obstruction 1 1 
Other 13 17 
Total 77 100 
Table 8. The distribution of clinical diagnoses seen in patients with 
Hashimoto's thyroiditis. 
Clinical diagnosis No. of cases, (%) 
Hashimoto's a 106, (83) 
Thyroid carcinoma 17, (13) 
Lymphoma 3, (2) 
Thyroid adenoma 2, (2) 
Total 128, (100) 
qncludes patients with Graves' Disease (3), goiter and HT (5), and 
probable Hashitoxicosis (2). 
the highest incidence occurring in women aged 20-39 years [22]. 
The above simply highlights the fact that the incidence of HT is 
much higher than is appreciated, largely because the majority of 
these patients remain asymptomatic or insufficiently sympto- 
matic to seek medical advice. Therefore, the 128 patients 
reviewed in this series are believed to represent  a highly select 
group of patients with problematic or symptomatic HT. As 
such, the 13% incidence of thyroid carcinoma in this group of 
patients with HT represents an overestimate of the frequency 
distribution of thyroid cancer occurring in HT. Regardless, this 
incidence is no greater than the incidence observed for minimal 
occult thyroid carcinoma in i00 consecutive autopsies per- 
formed at the University of Michigan Medical Center [18]. 
The findings that only 2 patients from this series of 128 
patients with HT had an associated benign adenoma and that 
the incidence of HT was observed to be only 2-5% in thyroid- 
ectomy specimens with either benign adenoma, multinodular 
goiter, or colloid nodules suggests that it may be misleading if 
this group is used as a control or comparison group to examine 
the incidence of HT in thyroid cancer versus benign thyroid 
disease. This is further suggested by the fact that the incidence 
of HT in all benign thyroid disease among the thyroidectomy 
specimens was 104 (17%) of 614. Consequently, using colloid 
nodules as an internal control for benign disease with which to 
compare the incidences of HT in cancer and benign thyroid 
disease as utilized by Ott et al. [4] may not be appropriate.  
However,  this point will require further investigation. 
Although Hashimoto 's  thyroiditis associated with thyroid 
cancer has been documented in 3 gifts with ages ranging from 10 
to 14 years [23], the finding of such a young patient in the female 
group perhaps deserves comment. The youngest patient was a 
4-year-old gift who had juvenile onset diabetes mellitus, a 
negative family history and a negative past medical history for 
other autoimmune diseases. She was euthyroid at presentation 
with a bilateral, diffuse goiter and positive antimicrosomal 
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antibodies. Initially, she received no treatment. However,  
because of the increasing size of her goiter, in the absence of 
any discrete mass or nodule, she was placed on thyroid medi- 
cation. During a 9-year follow-up she became hypothyroid and 
remained on thyroid medication until she was lost to follow-up. 
This case is consistent with the clonal-selection theory of 
immunity and highlights the precariousness of depending on the 
selective unresponsiveness of T-lymphocytes (suppressor T- 
cell lymphocyte function) to maintain tolerance to "se l f"  or 
autoantibodies [24]. Since the difference between the immune 
response in the fetus and the adult is merely quantitative, it is 
not unexpected that autoimmune disease can theoretically 
occur at any age. 
Moreover,  this patient with autoimmune disease involving 
her pancreas (islet cells) as well as her thyroid suggests that she 
should be carefully observed and screened for other organ- 
specific autoimmune diseases elsewhere, for example, her 
adrenal cortex (Schmidt 's  syndrome). As suggested by Clark et 
al., this child would need to be watched and screened carefully 
for Addison 's  disease in order to prevent inadvertent adrenal 
crisis [25]. 
It is apparent from this review that patients with HT who are 
at risk for harboring concurrent thyroid cancer are those who 
are found to have a cold or nonfunctioning thyroid nodule on 
99m technetium or 131I scan or those who present with a 
dominant thyroid mass that is nonsuppressible on adequate 
TSH suppression. Thyroid carcinoma was found in 32% of all 
cold thyroid nodules and 31% of all dominant thyroid masses in 
this series. These findings agree with the observations made by 
others [25, 26] and are consistent with the incidence of thyroid 
carcinoma in most clinical settings when associated with a 
solitary cold nodule [27-29]. In addition to a thyroid scan, Clark 
et al. recommend obtaining an ultrasound of the thyroid in 
evaluating patients with HT with a thyroid mass since, in their 
experience,  cystic nodules of the thyroid in patients with HT 
are rarely malignant and are most often successfully managed 
by percutaneous aspiration [30]. 
The indications for thyroidectomy in this series included: a 
dominant mass (discrete, clinically suspicious thyroid nodule or 
mass), signs of compression on the trachea and/or esophagus, a 
diffusely enlarged thyroid that is increasing in size despite TSH 
suppression, the failure of a thyroid nodule to regress while on 
thyroid replacement,  airway obstruction, or miscellaneous fac- 
tors such as hyperthyroidism secondary to autonomous func- 
tion or a cosmetically unattractive neck mass. 
In the absence of any of these findings or the demonstration 
of a dominant or solitary cold nodule, the management of 
patients with HT should include careful follow-up after the 
patient is on a stable regimen of adequate thyroid replacement 
(TSH suppression). 
We believe that this retrospective study of clinical and 
pathologic material does not support the hypothesis that HT is 
a predisposing factor for thyroid carcinoma. It is concluded that 
the association of HT with thyroid- carcinoma is relative, at 
best, and that it will be necessary to prospectively follow both 
large populations of patients with and without HT before this 
issue can be resolved. 
R~sum~ 
La thyroidite d 'Hashimoto (TH) est une maladie autoimmune 
de la thyroide qui provoque goitre et hyperthyroidisme. Bien 
que l 'association entre TH et lymphome de la thyroide soit bien 
6tablie, celle entre TH et cancer de la thyro~de reste confuse. 
Pour essayer de mieux 61ucider cette question, les auteurs ont 
revu r6trospectivement les comptes rendus d'histologie de 
routes les pi~ces de thyroidectomie, et les dossiers de tous le s  
patients admis pendant la p6riode 1975-1985 avec le diagnostic 
de TH ou de thyroidite lymphocytique chronique (TLC). I1 y 
avait 809 diagnostics enr6gistr6s pour 816 pi~ces de thyroidec- 
tomie provenant de 793 patients. En outre, 180 dossiers 
sur 228 6taient exploitables. Cent-vingt-huit patients seulement 
remplissaient les conditions diagnostiques de TH. T H o u  TLC 
6taient diagnostiqu6es dans 147 (18.2%) pi~ces sur 809. La  TH 
6tait associ6e avec un cancer dans 24% de tous les  cas de TH, 
alors que la TH 6tait associ6e h une maladie b6nigne de la 
thyroide dans 71% des cas de TH. La TH 6tait pr6sente dans 43 
(22%) sur 195 des cas de cancer de la thyroide. I1 y avait 111 
(87%) femmes et 17 hommes (13%). L'gtge moyen 6tait de 49 -+ 
14 ans. Quatre-vingt-huit patients (77%) avaient un goitre et 57 
(45%) une masse, 38 (67%) 6tant un nodule solitaire. Un patient 
(0.8%) avait d 'embl6e une paralysie r6currentielle et 12 (9%) 
avaient une compression trach6ale. Vingt-neuf (38.2%) patients 
seulement sur 76 avaient des anticorps antithyroglobuline 
thyroidiens, et 67 (87%) des 75 patients avaient des anticorps 
antimicrosomiaux. Soixante-dix patients (55%) ont eu une 
scintigraphie au technetium ou ~t 1'I 131: la thyroide 6tait 
h6t6rog~ne pour 75% d'entre  eux. Quatre-vingt un patients 
(71%) ont eu une hormonoth6rapie suppressive en premier, 
alors que 27 (21%) ont eu une thyroidectomie premiere. Ult6- 
rieurement, 60% des patients ont 6t6 thyroidectomis6s. 
L' indication principale de la chirurgie 6tait la pr6sence d 'une 
masse, trouv6e chez 40 (52%) des 77 patients. Seuls 17 (13%) 
patients avec une TH avaient un cancer simultan6 de la thy- 
ro~de; 3 (2%) avaient un lymphome associ6 ~t une TH. La 
fr6quence de cancer occulte dans une 6rude de 100 autopsies 
cons6cutives dans notre 6tablissement 6tait de 13%. Nous 
pensons que ces r6sultats sugg~rent que l 'association TH can- 
cer de la thyroide n 'es t  que fortuite. I1 est n6cessaire de suivre 
prospectivement un grand nombre de patients, divis6s en 2 
groupes, les uns avec TH, les autres sans, pour d6terminer avec 
pr6cision l ' incidence de cancer dans chaque groupe avant de 
r6soudre ce probl6me. 
Resumen 
La tiroiditis de Hashimoto (TH) es una enfermedad autoinmune 
de la tiroides, asociada con bocio e hipotiroidismo. Aunque 
existe una clara relaci6n entre TH y linfomas de la tiroides, la 
relaci6n entre TH y c~incer tiroideo no aparece clara. Con el ffn 
de evaluar este asunto, hemos revisado en forma retrospectiva 
tanto los informes de patologia de todos los especfmenes de 
tiroidectomfa, asi como las historias clfnicas de los pacientes 
admitidos al Centro M6dico de la Universidad de Michigan, 
Ann Arbor,  Michigan, con el diagn6stico de TH o de tiroiditis 
linfocftica cr6nica (TLC) en un perfodo de 10 afios (1975-1985). 
Se registraron 809 diagn6sticos patol6gicos de 816 especimenes 
de tiroidectomia en 793 pacientes. Adem~is, se dispuso de 180 
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de 228 historias cl/nicas para revisi6n. $61o 128 pacientes 
satisficieron nuestros criterios para el diagn6stico de TH. TH o 
TLC fueron diagnosticadas en 147 (18.2%) de 809 de los 
especimenes tiroideos. La TH ocurri6 en forma concurrente 
con el c~incer tiroideo en 24% de todos los casos de TH, en 
tanto que la TH ocurri6 en forma concurrente con enfermedad 
benigna de la tiroides en 71% de la totalidad de los casos de TH 
en todos los especfmenes tiroideos. Se encontraron 111 (87%) 
mujeres y 17 (13%) hombres de 128 pacientes cuyas historias 
clinicas fueron revisadas: la edad promedio fue 49 -+ 14 afios. 
Noventa y ocho (77%) de los pacientes presentaban bocio y 57 
(45%) presentaban masas tiroideas dominantes, de las cuales 38 
(67%) eran n6dulos solitarios. Un paciente (0.8%) se present6 
con parfilisis del nervio recurrente laringeo y 12 (9%) con 
compresi6n traqueal. $61o 29 (38.2%) de 76 pacientes investi- 
gados tenian titulos positivos de ATG, mientras 65 (87%) de 75 
tenfan tftulos AM positivos. Setenta (55%) fueron evaluados 
mediante escanografia con tecnecio o con 131I; se observ6 un 
patr6n heterog6neo en la gamagrafia en 75% de ellos. Noventa 
y uno (71%) fueron tratados inicialmente con supresi6n 
tiroidea. Sin embargo, 27 (21%) requirieron tiroidectomfa en su 
manejo inicial. A1 final 60% requirieron tiroidectomfa y 37% no 
la requirieron. La indicaci6n mayor para intervenci6n 
quirtirgica fue |a presencia de una masa dominante en 40 (52%) 
de 77 pacientes. $61o 17 (13%) pacientes exhibieron cfincer 
tiroideo concomitante con TH y 3 (2%) presentaron linfoma con 
TH. La incidencia de cfincer minimo (oculto) en un estudio de 
100 autopsias consecutivas en nuestra instituci6n fue 13%. 
Consideramos que estos datos sugieren que la relaci6n entre 
TH y c~ncer tiroideo es apenas relativa, en el mejor de los 
casos. Ser~i necesario hacer el seguimiento prospectivo de un 
grupo grande de pacientes con TH y de un grupo control sin TH 
para detectar la incidencia de c~incer tiroideo en cada grupo 
para poder enfocar en forma apropiada este asunto. 
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